High expression of MHC I in the tibialis anterior muscle of a paraplegic patient
✍ Scribed by Andreas Hartkopp; Jesper L. Andersen; Stephen D.R. Harridge; Clarissa Crone; Tom Gruschy-Knudsen; Michael Kjær; Mizuno Masao; Aivaras Ratkevicius; Bjørn Quistorff; Shi Zhou; Fin Biering-Sørensen
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 344 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
✦ Synopsis
A long-term paraplegic man presented exclusively (>99%) myosin heavy chain I (MHC I) in the tibialis anterior muscle (TA). This was coupled to a slow speed of contraction, a high resistance to fatigue, and a rapid resynthesis of phosphocreatine after an electrically evoked fatiguing contraction when compared with the TA muscles of 9 other paraplegic individuals. In contrast, the MHC composition of his vastus lateralis, gastrocnemius, and soleus muscles was that expected of a muscle from a spinal cord injured individual. This information may be of clinical importance in terms of the expected morphological and functional adaptations of skeletal muscle to different types of electrical stimulation therapy.
📜 SIMILAR VOLUMES
## Abstract ## Objective High mobility group box chromosomal protein 1 (HMGB‐1) is an endogenous nuclear protein that can be translocated to the cytoplasm and then released extracellularly. It can induce tumor necrosis factor and interleukin‐1 production in myeloid cells. Increased expression of t
Various mutations of genes encoding type I procollagen chains have been linked to osteogenesis imperfecta (OI). The mutations yield abnormal procollagen molecules that fold improperly. HSP 47, a stress-inducible protein localized to the endoplasmic reticulum (ER) of collagen-producing cells, may par
## Abstract ## Objective To investigate the relationship between the vasculopathy of juvenile dermatomyositis (juvenile DM) and the balance between the angiostatic ELR− and angiogenic ELR+ CXC chemokines in the muscle of patients with the disease. ## Methods The expression of 3 ELR− CXC chemokin